EUVIMEDEUVIMED entdecken
Crossref

Effect of Enhanced Recovery after Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction

Kristen L Stephens iD, Robert G DeVito, Scott T Hollenbeck, Chris A Campbell, John T Stranix

Journal of Reconstructive Microsurgery · 01.11.2025 · 41 (09) · 733-740

DOI: 10.1055/a-2506-1763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Reconstructive Microsurgery, erschienen am 01.11.2025. Verfasst von Kristen L Stephens und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia. Hauptthemen laut MEDLINE: Mammaplasty, Obesity, Morbid, Enhanced Recovery After Surgery, Free Tissue Flaps. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Enhanced recovery after surgery (ERAS) pathways have been widely implemented across many surgical practices, including autologous breast reconstruction. However, the benefits of ERAS in the morbidly obese population have yet to be defined. A retrospective chart review of patients undergoing deep inferior epigastric artery perforator (DIEP) flap breast reconstruction at our institution from 2017 to 2022 was performed. Length of stay (LOS), intensive care unit (ICU) utilization, opioid usage, cost, and flap outcomes were analyzed in patients with body mass index greater than 35 before and after ERAS implementation. Thirty-five morbidly obese patients receiving DIEP flap breast reconstruction were identified before ERAS and 18 after ERAS. There were no differences in unilateral versus bilateral or immediate versus delayed reconstruction. LOS decreased with ERAS (3.43 vs. 2.06 days, p < 0.0000001). ICU utilization decreased with ERAS (0.94 vs. 0.0 days, p < 0.0001). Daily and total opioid usage decreased with ERAS (41.8 vs. 17.9 morphine milligram equivalent [MME], p < 0.0001; 190.5 vs. 54.7 MME, p < 0.0001). Financial metrics improved with ERAS, including decreased total cost ($33,454 vs. $25,079, p = 0.0002) and increased cost margin ($4,458 vs. −$8,306, p = 0.004). There were no differences in donor or recipient site outcomes including flap loss, deep venous thrombosis/pulmonary embolism, hernia/bulge, delayed wound healing, revisions, and blood loss. ERAS pathways maintain benefits in the morbidly obese population undergoing abdominally based autologous breast reconstruction, including decreased LOS, ICU utilization, opioid use, and cost while maintaining successful reconstruction outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MammaplastyObesity, MorbidEnhanced Recovery After SurgeryFree Tissue FlapsPerforator FlapBreast NeoplasmsHumansFemaleRetrospective StudiesMiddle AgedLength of StayAdultTreatment OutcomeEpigastric Arteries

Autor:innen und Institutionen

  • Department of Plastic Surgery, University of Virginia, Charlottesville, Virginia.

ORCID-Profile: Kristen L Stephens

Zitieren

APA

Stephens, K. L., DeVito, R. G., Hollenbeck, S. T., Campbell, C. A., & Stranix, J. T. (2025). Effect of Enhanced Recovery after Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction. Journal of Reconstructive Microsurgery, 41(09), 733-740. https://doi.org/10.1055/a-2506-1763

Vancouver

Stephens KL, DeVito RG, Hollenbeck ST, Campbell CA, Stranix JT. Effect of Enhanced Recovery after Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction. Journal of Reconstructive Microsurgery. 2025;41(09):733-740. doi:10.1055/a-2506-1763

BibTeX
@article{Stephens2025,
  author = {Stephens, Kristen L and DeVito, Robert G and Hollenbeck, Scott T and Campbell, Chris A and Stranix, John T},
  title = {Effect of Enhanced Recovery after Surgery in Morbidly Obese Patients Undergoing Free Flap Breast Reconstruction},
  journal = {Journal of Reconstructive Microsurgery},
  year = {2025},
  volume = {41},
  number = {09},
  pages = {733--740},
  doi = {10.1055/a-2506-1763}
}
Kostenlos starten →